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Gene Expression Profiling of the Leading Edge
of Cutaneous Squamous Cell Carcinoma:
IL-24-Driven MMP-7
Hiroshi Mitsui1, Mayte Sua´rez-Farin˜as1,2, Nicholas Gulati1, Kejal R. Shah3, Maria V. Cannizzaro1,4,
Israel Coats1, Diane Felsen5, James G. Krueger1 and John A. Carucci6
The precise mechanisms governing invasion at the leading edge of squamous cell carcinoma (SCC) and its
subsequent metastasis are not fully understood. We aimed to define the cancer-related molecular changes that
distinguish noninvasive tumor from invasive SCC. To this end, we combined laser capture microdissection with
complementary DNA (cDNA) microarray analysis. We defined invasion-associated genes as those differentially
regulated only in invasive SCC nests, but not in actinic keratosis or in situ SCC, compared with normal epidermis.
There were 383 upregulated and 354 downregulated genes in the ‘‘invasion set.’’ SCC invasion was characterized
by aberrant expression of various proteolytic molecules. We noted increased expression of MMP7 and IL-24 in
invasive SCC. IL-24 induced the expression of matrix metallopeptidase 7 (MMP7) in SCC cells in culture. In
addition, blocking of MMP7 by a specific antibody significantly delayed the migration of SCC cells in culture.
These results suggest a possible contribution of IL-24 to SCC invasion via enhancing focal expression of MMP7,
although IL-24 has been suggested to have antitumor growth effects in other cancer types. Identification of
regional molecular changes that regulate cancer invasion may facilitate the development of new targeted
treatments for aggressive cancer.
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INTRODUCTION
Cutaneous squamous cell carcinoma (SCC), the second most
frequent skin cancer, arises from interfollicular epidermal
keratinocytes. Transformed malignant cells can proliferate in
the epidermis as in situ SCC, eventually cross the basement
membrane, and enter the dermis to form invasive SCC.
Invasion to the dermis is a critical event, as cancer cells are
allowed to access lymphatic and to a lesser degree blood
vessels, which may result in metastasis. The American Joint
Committee on Cancer, in fact, added tumor depth (42-mm
thickness or Clark level XIV) as a high-risk feature of SCC
(Farasat et al., 2011). Although usually curable by resection,
SCC accounts for the majority of B10,000 deaths from
nonmelanoma skin cancer in the United States each year
(Weinberg et al., 2007).
Cancer invasion can be mediated by several processes
including degradation of extracellular matrix and growth and
migration of tumor cells into surrounding stromal regions.
Thus, studying the expression and regulation of tumor growth
factors and proteolytic molecules within a tissue is important.
Gene expression analysis, such as complementary DNA
(cDNA) microarray analysis, has been applied to many cancer
types including cutaneous SCC (Dooley et al., 2003; Haider
et al., 2006; Kathpalia et al., 2006; Nindl et al., 2006; Hudson
et al., 2010; Padilla et al., 2010). These prior studies identified
numerous genes that might be involved in SCC pathogenesis.
For example, we reported that matrix metallopeptidases
(MMPs) including MMP1, MMP10, and MMP13 were
selectively expressed in SCC but not in psoriasis, a benign
inflammatory skin disease characterized by epidermal
hyperproliferation, but without invasion into the dermis by
keratinocytes (Haider et al., 2006). This suggests the potential
importance of these MMPs in SCC progression.
Cytokines also have significant functions in tumor biology.
T helper type 1 cytokines, such as IFN-g, have been thought to
possess antitumor properties, whereas T helper type 2 cyto-
kines, such as IL-4, have primarily protumor activity. Recent
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studies, however, reveal that the cytokines, such as IFN-g,
possess both anti- and pro-tumor activities depending on the
tumor types as well as the tumor microenvironment (Zaidi and
Merlino, 2011). IL-24, also known as melanoma differentia-
tion associated gene-7 (mda-7), is a member of the IL-10
family of cytokines. It was initially found as a growth inhibitor
of melanoma (Jiang et al., 1995). Mounting evidence
established a role of IL-24 in inducing apoptosis and cell
death in many solid cancers including melanoma as well as
epithelial carcinomas of various organs (Dash et al., 2010).
However, phase I clinical study using an adenovirus
containing IL-24/mda-7 construct (Ad.IL24/mda-7, INGN241)
was not able to control tumor growth of a penile, and a head
and neck SCC (Cunningham et al., 2005). IL-24 is known to be
highly produced in psoriasis lesional skin (Rmer et al., 2003).
In addition, IL-24 was as potent as IL-22 to induce
keratinocytic hyperplasia in a reconstituted human epidermis
culture model (Sa et al., 2007). It was thus speculated that
IL-24 might have distinct functions in cutaneous SCC growth
as opposed to antitumor functions established in other
cancer types.
Cancer cells may change their phenotypes along with tumor
progression, i.e., a switch of E-cadherin to N-cadherin expres-
sion (Hazan et al., 2004) and an epithelial-to-mesenchymal
transition in invading tumor cells (Thiery et al., 2009). Cells at
the invading front might, thus, be genomically distinct from
bulk tumor cells. Therefore, we used laser capture micro-
dissection (LCM) in order to collect subpopulations of SCC
cells from human skin tissue. We generated the invasion
signature gene set of cutaneous SCC, a set of genes that
were differentially regulated in SCC invasive nests, but
not in actinic keratosis (AK) or in situ SCC regions,
compared with normal epidermis. We identified significant
upregulation of IL-24 and MMP7 mRNA in the invading front
of cutaneous SCC. Molecular interaction of these two
molecules and their potential role in SCC progression are
discussed in this study.
RESULTS
LCM combined with cDNA microarray analysis provides specific
gene expression profiles for various stages of SCC progression
Tumor debulking samples were obtained during Mohs micro-
graphic surgery for SCC. Three transformed epidermal regions
in this study that represent the transition to invasive SCC were
defined as follows: (1) AK (atrophic type), regions of severe
dysplasia at the basal layer of atrophic epidermis with solar
elastosis in dermis, (2) in situ SCC, tumor regions with
transformed keratinocytes throughout the entire epidermis that
have not crossed the basement membrane, and (3) invasive
SCC, tumor nests that have invaded the dermis and discon-
nected from the bulk tumor mass (Figure 1a). There were 724
upregulated and 820 downregulated probe sets in AK, 1,042
upregulated and 1,200 downregulated probe sets in in situ
SCC, and 1,325 upregulated and 1,461 downregulated probe
sets in invasive SCC compared with microdissected normal
epidermis (fold change 43.0 and false discovery rate o0.05;
Figure 1a). A Venn diagram demonstrated 1,083 (503 upre-
gulated and 580 downregulated) commonly regulated probe
sets among the three regions, including S100As, KRT6, and
serpins (Figure 1b and c). A group of genes that was selectively
regulated in invasive SCC, but not in dysplasia or in situ SCC,
was of particular interest as these genes might have significant
roles in SCC invasion to the dermis. This consists of 383
upregulated and 354 downregulated probe sets and these genes
were designated as invasion signature genes (Supplementary
Table S1 online). The complete gene lists comparing each
region with microdissected normal epidermis are found in
Supplementary Tables S2–S4 online.
The invasion signature gene set characterized the tumor nests at
the invasion front
Table 1 shows selected up- and down-regulated invasion
signature genes. Genes encoding proteolytic molecules, such
as MMPs and PLAU, were highly upregulated. A cell adhesion
molecule LAMC2 was also upregulated. The expression of
podoplanin (PDPN) in cutaneous SCC was reported previously
by quantitative reverse transcriptase–PCR (RT–PCR) and by
immunohistochemistry (Schacht et al., 2005; Moussai et al.,
2011). In contrast, melanocyte-related genes such as TYRP1,
DCT, and KIT, as well as keratinocyte differentiation markers
including FLG, LOR, and LCE2B, were downregulated.
Ingenuity pathway analysis linked 28 canonical pathways to
the SCC invasion signature gene set (Supplementary Table S5
online, Fisher’s exact test, Po0.05). The most significant path-
way was leukocyte extravasation signaling (P¼9.56 104),
followed by Aryl hydrocarbon receptor signaling (P¼1.46
 103), and hypoxia-inducible factor-1a signaling
(P¼ 1.54 10 3).
Regional expression of MMPs in the SCC tissue was mapped
using preamplification quantitative RT–PCR
The expression of MMPs in SCC invasion nests was further
investigated, as three of the top six genes in the invasion
signature gene set were MMPs (MMP3, MMP12, and MMP13)
and MMPs are critical for degrading the extracellular matrix
surrounding tumor nests. Eleven MMPs were detected as
differentially expressed probe sets along with SCC progression
by microarray analysis (Table 2). The expression of MMP9,
MMP11, and MMP14 was increased even in AK. The expres-
sion of MMP1, MMP2, and MMP10 started to elevate in in situ
SCC, and further increased in invasive SCC by B2- to 7-fold
compared with in situ SCC. MMP1 was the most abundant
MMP in invasive SCC with a fold change¼ 107.82, followed
by MMP10 with a fold change¼48.35. The expression of
MMP3, MMP7, MMP12, MMP13, and MMP17 was selective
for invasive SCC. The regional expression difference of all 23
known human MMPs was further tested using the same RNA
used for microarray analysis by a more sensitive RT–PCR
detection. A heat map clearly showed the increase of expres-
sion of multiple MMPs toward invasive SCC (Figure 2a).
Out of 23 genes tested, 12 had significant difference among
the four keratinocytic regions (Po0.05, Figure 2b–e and
Supplementary Figure S1 online). Of these 12 genes, 11 were
upregulated in cancer regions compared with normal epider-
mis or AK. The expression of MMP28 was lower in in situ SCC
than in normal epidermis. This was consistent with a previous
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report showing the specific expression of MMP28 in prolifer-
ating keratinocytes during wound healing, but not in SCC
(Saarialho-Kere et al., 2002). The mRNA of MMP8, MMP20,
MMP23B, MMP26, and MMP27 was rarely detected in any
keratinocytic regions tested (Supplementary Figure S1 online).
In addition, proportional odds model identified 14 MMPs
as statistically significant (* in Figure 2a, P-values in
Supplementary Table S6 online). This indicates that gene
expression of these MMPs increases the odds of being in a
phenotype of higher degree of malignancy. The results of
cDNA microarray and preamplification RT–PCR were posi-
tively correlated as evidenced by Pearson’s r¼ 0.788
(Po0.0001), when the 11 genes detected in both methods
were compared (Supplementary Figure S2 online).
Altered protein expression of the selected genes was confirmed
by immunohistochemistry
Immunohistochemistry was performed in order to confirm
the altered protein expression of the corresponding
genes within tissue. MMP1, the most upregulated MMP on
our gene list, strongly stained both SCC tumor nests and the
interstitial region surrounding tumor nests (Figure 2f–g). Stain-
ing of MMP3 and MMP7 was selective in the invading cancer
cells, but not in the epidermis of normal skin or the epidermis
above the tumor nests (Figure 2h–k), thus confirming the
specificity and gradual increase of the mRNA expression in
tumor nests. MMP10 strongly stained tumor nests in the
dermis, but it also stained the basal layer of keratinocytes in
normal skin (Figure 2l–m). These genomic and protein data
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Figure 1. Combined laser capture microdissection (LCM) and complementary DNA (cDNA) microarray analysis identified region-specific gene expression
changes in the squamous cell carcinoma (SCC) tissues. (a) Images of hematoxylin and eosin (H&E) staining for each region and number of differentially expressed
probe sets identified in the corresponding regions compared with normal epidermis. Top panels indicate lower magnification, middle panels indicate higher
magnifications, and bottom panels indicate images of LCM. Bar¼ 100mm. AK, actinic keratosis. (b) A Venn diagram revealed the numbers of commonly regulated
probe sets among the dysplasia/cancer regions compared with normal epidermis as well as uniquely regulated probe sets in the SCC invasion nests. (c) The top 10
common up- and downregulated probe sets among the three dysplasia/cancer regions compared with normal epidermis are listed. The numbers in red indicate
upregulated probe sets, whereas those in green indicate downregulated probe sets. DEGs, differentially expressed genes.
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Table 1. Selected (a) upregulated and (b) downregulated SCC invasion signature genes
AK SCC in situ SCC invasion
Symbol FCH FDR FCH FDR FCH FDR Description
(a) Selected upregulated SCC invasion signature genes
MMP12 1.14 0.90 2.31 0.37 32.97 o0.01 Matrix metallopeptidase 12
PTHLH 0.76 0.67 3.09 0.05 17.89 o0.01 Parathyroid hormone-like hormone
MMP3 1.19 0.89 4.77 0.15 16.38 o0.01 Matrix metallopeptidase 3
AIM2 1.80 0.34 2.72 0.08 14.61 o0.01 Absent in melanoma 2
NEFL 0.87 0.83 2.23 0.13 13.34 o0.01 Neurofilament, light polypeptide
MMP13 0.96 0.95 2.37 0.11 12.53 o0.01 Matrix metallopeptidase 13
KRT19 1.17 0.78 2.80 0.02 11.33 o0.01 Keratin 19
INHBA 0.86 0.80 2.42 0.07 10.89 o0.01 Inhibin, bA
IL7R 1.62 0.36 2.86 0.03 9.45 o0.01 Interleukin 7 receptor
CXCL10 3.63 0.24 5.26 0.11 9.44 0.02 Chemokine (C-X-C motif) ligand 10
SPP1 1.45 0.70 2.18 0.37 8.76 o0.01 Secreted phosphoprotein 1
PLAU 2.60 o0.01 2.73 o0.01 8.45 o0.01 Plasminogen activator, urokinase
PDPN 0.41 0.01 2.11 0.03 8.04 o0.01 Podoplanin
KRT18 2.24 0.16 2.80 0.06 7.69 o0.01 Keratin 18
FN1 0.67 0.61 3.30 0.09 7.06 o0.01 Fibronectin 1
APOBEC3G 2.45 0.03 2.55 0.02 6.96 o0.01 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
LAMC2 0.79 0.69 1.17 0.77 6.77 o0.01 Laminin, g2
IL24 1.20 0.79 2.03 0.23 6.74 o0.01 Interleukin 24
CXCR4 2.60 0.09 1.78 0.31 6.16 o0.01 Chemokine (C-X-C motif) receptor 4
MMP7 1.09 0.89 1.16 0.77 5.43 o0.01 Matrix metallopeptidase 7
(b) Selected downregulated SCC invasion signature genes
TYRP1 0.79 0.88 0.45 0.54 0.03 o0.01 Tyrosinase-related protein 1
FLG 0.60 0.70 0.14 0.09 0.04 o0.01 Filaggrin
LOR 1.39 0.80 0.25 0.21 0.07 0.01 Loricrin
TFAP2B 1.17 0.83 0.36 0.10 0.07 o0.01 Transcription factor AP-2b
HPGD 0.41 0.18 0.29 0.05 0.08 o0.01 Hydroxyprostaglandin dehydrogenase
DCT 1.24 0.81 0.31 0.11 0.08 o0.01 Dopachrome tautomerase
NFIB 0.61 0.38 0.36 0.04 0.10 o0.01 Nuclear factor I/B
CYorf15B 0.40 0.38 0.23 0.12 0.11 0.02 Chromosome Y open reading frame 15B
DDAH1 1.18 0.74 0.73 0.50 0.12 o0.01 Dimethylarginine dimethylaminohydrolase 1
CHI3L1 0.76 0.73 0.33 0.11 0.12 o0.01 Chitinase 3-like 1
LCE2B 1.15 0.87 0.25 0.05 0.13 o0.01 Late cornified envelope 2B
ANXA9 1.17 0.81 0.54 0.26 0.13 o0.01 Annexin A9
NEB 1.06 0.90 0.41 0.02 0.13 o0.01 Nebulin
ALOX12 1.26 0.47 0.38 o0.01 0.14 o0.01 Arachidonate 12-lipoxygenase
CEP76 0.46 0.09 0.40 0.04 0.14 o0.01 Centrosomal protein 76 kDa
ACSBG1 0.93 0.89 0.38 0.02 0.15 o0.01 Acyl-CoA synthetase bubblegum family member 1
KIT 0.64 0.43 0.42 0.09 0.16 o0.01 v-kit Hardy-Zuckerman 4 feline Sarcoma viral oncogene homolog
NFASC 0.38 o0.01 0.36 0.00 0.16 o0.01 Neurofascin homolog
AADAC 1.34 0.54 0.47 0.08 0.16 o0.01 Arylacetamide deacetylase
ATP6V0E2 0.80 0.55 0.38 0.00 0.17 o0.01 ATPase, Hþ transporting V0 subunit e2
Abbreviations: AK, actinic keratosis; FCH, fold change; FDR, false discovery rate; SCC squamous cell carcinoma.
FCH and FDR in SCC invasion are in bold.
H Mitsui et al.
Cancer Cell–Derived Invasion-Regulating Genes
www.jidonline.org 1421
provide the localization of MMPs within the cutaneous SCC
tissues.
IL-24 was increased in SCC invasion front and upregulated the
expression of MMP7 in SCC cells in vitro
IL-24 was upregulated in our SCC invasion signature gene set
(Table 1a). The mRNA and protein expression of IL-24 as well
as its receptor subunits (IL-20R1, IL-20R2, and IL-22R1) within
the tissues was confirmed. The expression of IL-24 mRNA was
detected only in in situ SCC and invasive SCC, but not in AK
(Figure 3a). An IL-24 antibody detected signals in SCC tumor
nests, but not normal skin (Figure 3b and c). The mRNA of the
three receptor subunits was constitutively expressed in all
regions, although IL20R1 was slightly decreased in invasive
SCC (Figure 3d–f). It has been reported that some cytokines,
including transforming growth factor-a, enhance the expres-
sion of IL-24 in HaCaT cells as well as normal human
epidermal keratinocytes (Poindexter et al., 2010). The
expression of IL-24 mRNA in two human cutaneous SCC
cell lines was thus investigated (see detailed descriptions of
these cells in the Supplementary Materials and Methods
online). SCC13 cells (Rheinwald and Beckett, 1981)
constitutively expressed IL-24 mRNA without addition of any
cytokines. This expression was further increased by stimula-
tion with transforming growth factor-a, tumor necrosis factor-
a, and IFN-g (Figure 3g). A431 cells, another SCC cell line
(Giard et al., 1973; Price et al., 1988), did not express IL-24
regardless of the stimuli (data not shown). IL-24 utilizes the
same receptors to activate cells as IL-20 (Sabat, 2010), and IL-
20 has been reported to upregulate the expression of MMP7 in
HaCaT cells (Wang et al., 2006). Hence, we hypothesized that
IL-24 might play a role in upregulating the expression of
MMP7 mRNA in SCC. MMP7 mRNA in A431 or HaCaT cells
was increased when cultured with 40 or 100 ng ml 1 of IL-24,
or 100 ng ml 1 of IL-20 for 24 hours (Figure 3h and i). MMP7
mRNA was not increased in SCC13 cells with the addition of
IL-20 or IL-24 (Figure 3j), although SCC13 cells expressed
IL-24 mRNA constitutively. This might, in part, be explained
by significantly lower expression of the IL-24 receptor subunits
in SCC13 cells as compared with others (Supplementary
Figure S3 online). Nevertheless, these data suggest a role of
IL-24 in enhancing the expression of MMP7 in SCC cells that
may contribute to cancer progression.
Blocking of MMP7 by a specific antibody significantly delayed
the migration of A431 cells
Finally, the function of MMP7 in A431 cells was examined
using a scratch assay. A431 cells were selected as this cell line
expresses B50-fold higher MMP7 mRNA than the other two
cell lines tested (Figure 3h–j). A scratch was made when A431
cells reached 90% confluence, and they were maintained in
the 0.1% fetal bovine serum (FBS)–containing media with or
without an MMP7 antibody (MMP7Ab). The MMP7Ab used
in this experiment was shown to block the activity of MMP7
(Ito et al., 2007). Figure 4a–d shows the gap between cells
after a 36-hour treatment with phosphate-buffered saline
alone (Figure 4a) or different concentrations of the MMP7Ab
(20 ng ml 1 (Figure 4b), 200 ng ml 1 (Figure 4c), and
2,000 ng ml1 (Figure 4d)). The effect of blocking MMP7
was evaluated by calculating a percent confluence for each
condition at each time point. The MMP7Ab significantly
delayed the migration of A431 cells at a concentration of
2,000 ng ml1 as compared with the other conditions
(Figure 4e). This was also true after a 24-hour treatment
with the MMP7Ab treatment at 2,000 ng ml1 compared
with phosphate-buffered saline and 20 ng ml 1 MMP7Ab
(Figure 4f). A similar effect was observed when the A431
cells were maintained in media containing 10% FBS
(Supplementary Figure S4 online). These results suggest the
involvement of MMP7 in the migration of cutaneous SCC.
DISCUSSION
Previous studies including our own have examined gene
expression profiling of cutaneous SCC using total RNA
extracted from full-thickness tumor tissues (Dooley et al.,
2003; Haider et al., 2006; Kathpalia et al., 2006; Nindl
et al., 2006; Hudson et al., 2010; Padilla et al., 2010). To
our knowledge, no studies combining LCM and cDNA
microarray analysis on cutaneous SCC have been published.
This study confirmed many genes of previous findings, i.e., the
enhanced expression of epidermal differentiation complex
genes, such as S100As, SPRRs, IVL, and LCE3D. Hudson
et al. (2010) proposed the expression of KRT13 as a marker of
SCC. In this study, we found that KRT13 is specific to in situ
and invasive SCCs, but not AK. Thus, our study is unique in
localizing hundreds of gene products to different stages of
tumor progression in vivo by combining LCM and cDNA
microarray analysis. This helps to identify molecular
interactions that may happen in focal regions of SCC. One
such example is the focal regulation of MMP7 by IL-24
cytokine.
Table 2. MMP expression across regions measured by
cDNA microarray analysis
AK SCC in situ SCC invasion
Symbol FCH FDR FCH FDR FCH FDR
MMP9 3.42 0.03 3.85 0.01 19.31 o0.01
MMP11 3.05 o0.01 5.57 o0.01 5.77 o0.01
MMP14 3.08 o0.01 4.06 o0.01 3.91 o0.01
MMP1 1.28 0.87 16.61 0.02 107.82 o0.01
MMP2 1.05 0.93 5.85 o0.01 10.50 o0.01
MMP10 1.14 0.89 7.21 o0.01 48.35 o0.01
MMP3 1.19 0.89 4.77 0.15 16.38 o0.01
MMP7 1.09 0.89 1.16 0.77 5.43 o0.01
MMP12 1.14 0.90 2.31 0.37 32.97 o0.01
MMP13 1.04 0.95 2.37 0.11 12.53 o0.01
MMP17 2.62 o0.01 2.81 o0.01 3.50 o0.01
Abbreviations: AK, actinic keratosis; cDNA, complementary DNA; FCH,
fold change; FDR, false discovery rate; MMP, matrix metallopeptidase; SCC
squamous cell carcinoma.
FCH for the genes that satisfied the differential expression criteria is shown
in bold.
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IL-24 has been shown to induce apoptosis and cell death in
many solid cancers (Dash et al., 2010). Its expression has been
inversely correlated with lymph node metastasis or overall
survival in some cancers (Ishikawa et al., 2005; Patani et al.,
2010; Choi et al., 2011). However, a phase I clinical study
of intratumoral injections of Ad.IL24/mda-7 resulted in
progressive disease in two cases of SCC (Cunningham
et al., 2005). New nodules arose around the periphery of
the skin nodule of penile SCC after treatment. These results
may thus suggest a putative pro-oncogenic function of IL-24 in
SCC growth. Our findings may support this notion. We found
that IL-24 was significantly overexpressed at the invasion nest
of SCC. IL-24 mRNA was constitutively expressed in SCC13
cells and this was further enhanced by culturing with tumor
necrosis factor-a, transforming growth factor-a, and IFN-g. The
cellular source of IL-24 may, however, be more complicated
within the SCC microenvironment. T helper type 2 cells and
macrophages as well as melanocytes produce IL-24
(Poindexter et al., 2005), and these cells reside in the SCC
microenvironment. In fact, IL-24 mRNA was also upregulated
in inflammatory infiltrating cell regions surrounding tumor
nests compared with normal reticular dermis (Belkin et al.,
2013). We thus concluded that IL-24 can be derived from
multiple cell types including cancer cells within the SCC
microenvironment. We have previously reported that IL-24
promoted neither proliferation nor apoptosis of A431 cells
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Figure 2. Mapping the regional expression differences of known matrix metallopeptidases (MMPs) was performed by reverse transcriptase–PCR (RT–PCR) and
immunohistochemistry (IHC). (a) A heat map of mean expression of all MMPs tested across the regions is shown. AK, actinic keratosis. (b–e) RT–PCR was
performed for (b) MMP1, (c) MMP3, (d) MMP7, and (e) MMP10 (n¼ 5 for each region). The y-axis shows relative expression level of each gene compared with the
housekeeping gene RPLP0/hARP in Log2 (mean±SEM). A P-value was estimated among four keratinocytic regions (one-way analysis of variance (ANOVA) with
Tukey’s correction). The resultant P-values are shown in parentheses. A line between two bars indicates statistical significance between two cell types. (f–m)
Corresponding protein product was detected by IHC for (f, g) MMP1, (h, i) MMP3, (j, k) MMP7, and (l, m) MMP10. Upper panels indicate normal skin, and lower
panels indicate squamous cell carcinoma (SCC). Dotted lines indicate borders between epidermis/tumor nests and dermis. Bar¼ 100mm.
H Mitsui et al.
Cancer Cell–Derived Invasion-Regulating Genes
www.jidonline.org 1423
when cultured in a starvation condition (0.1% FBS) (Zhang
et al., 2013). Instead, we report herein a function of IL-24 in
increasing the expression of MMP7 in SCC cells.
The mRNA of MMP7 was specifically upregulated in the
invasion nests. The expression of MMP7 was enhanced under
a hypoxic condition in colon cancer cells (Remy et al., 2006).
Ingenuity pathway analysis associated the genomic profile of
invasive SCC with hypoxia-inducible factor-1a signaling.
Thus, the microenvironment of the invasive tumor front may
be prone to induce MMP7 by multiple mechanisms. We
confirmed the function of MMP7 in the migration of cutaneous
SCC cells. The migration of A431 cells was significantly
delayed by a specific MMP7Ab in a dose-dependent manner.
MMP7 has been shown to be involved in the tumor migration
of various cancers through multiple pathways. One such
mechanism is proposed in colon cancer cells, where MMP7
cleaves b3 chain of laminin332, resulting in enhancing
migration capacity (Remy et al., 2006). Laminin332 can be
processed by various enzymes and its remodeling has been
implicated in SCC migration (Marinkovich, 2007). All subunits
of laminin332 were significantly upregulated along with SCC
progression (Supplementary Table S4 online). Taken together,
these results may suggest a function of MMP7 in SCC
migration via accelerating laminin332 remodeling. In addi-
tion, it has been demonstrated that MMP7 shed E-cadherin
and released an 80-kDa fragment of E-cadherin from A431
cells that would facilitate an epithelial-to-mesenchymal transi-
tion-like process (Shibata et al., 2009). MMP7 also sheds pro-
heparin-binding EGF to yield mature heparin-binding EGF
(Hashimoto et al., 2002). Overall, MMP7 enhances prolife-
ration, migration, and invasion of cancer cells (Ii et al., 2006).
However, we acknowledge that the effect of blockade of
MMP7 in 0.1% FBS-containing media was partially
diminished in the 10% FBS-containing media, indicating the
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Figure 3. IL-24 induced the expression of matrix metallopeptidase 7 (MMP7) in HaCaT and A431 cells. (a–c) IL-24 expression was examined at the mRNA level
(a) and at the protein level in (b) normal skin and (c) squamous cell carcinoma (SCC). Bar¼ 100mm. (d–f) mRNA expression of (d) IL-20R1, (e) IL-20R2, and
(f) IL-22R1 was examined. (g) Expression levels of IL-24 mRNA in SCC13 cells after a 12-hour treatment with phosphate-buffered saline (PBS) or indicated
cytokines are shown. AA, acidic acetate; AK, actinic keratosis. (h–j) Expression of MMP7 mRNA in the three cell lines was evaluated after a 24-hour treatment with
PBS, IL-24 (40 and 100 ng ml1), or IL-20 (100 ng ml 1). Relative expression compared with RPLP0/hARP in Log2 is shown for all RT–PCR results (mean±SEM). A
line between two bars indicates statistical significance between the two conditions (one-way analysis of variance (ANOVA) with Tukey’s correction). ***Po0.0001
against both PBS and AA (repeated measures ANOVA with Tukey’s correction).
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contribution of other factors to the migration of A431 cells.
There was a discrepancy between the expression of IL-24 and
MMP7 in the two SCC cell lines tested. It should be noted that
strong expression of MMP7 was observed in the aggressive
A431 cells. However, the less aggressive SCC13 cells and
HaCaT cells, the immortalized keratinocytes, had only weak
or absent expression of MMP7. This observation may support
an important role of MMP7 in SCC migration. The function of
IL-24 or MMP7 needs to be conclusively demonstrated using
appropriate in vivo models. However, current mouse models
of SCC do not properly recapitulate human SCC, because
mouse SCCs feature follicular differentiation. Therefore,
development of the animal models that accurately represent
invasion of human SCC is needed.
In summary, we characterized gene expression profiling of
invasion front of SCC compared with laser captured AK and
SCC that have not invaded the dermis. We suggest a pro-
oncogenic role of IL-24 in cutaneous SCC, unlike other cancer
types, via inducing MMP7 expression in cancer cells. Further
elucidation of the mechanisms governing regulation of inva-
sion by SCC will allow for development of targeted therapy for
aggressive disease not amenable to conventional intervention.
MATERIALS AND METHODS
The detailed protocols and statistical analysis are described in the
Supplementary Materials and Methods online.
Patients and samples
Institutional review board (The Rockefeller University and Weill
Cornell Medical College) approval and written informed consent
were obtained before enrolling patients to participate in this study.
The study was performed in adherence with the Declaration of
Helsinki Principles. Cutaneous SCC samples were obtained from
debulking during Mohs micrographic surgery. All tumors were
obtained from sun-exposed skin.
LCM
Eight SCC tissues were subjected to LCM following the manufacturer’s
protocol for CellCut system (Molecular Machines and Industries,
Haslett, MI). Normal skin samples used in this study (n¼ 10) as a
reference came from our previous study (Kennedy-Crispin et al., 2012).
RNA extraction and quantification
RNA extraction was performed using RNeasy Kit (QIAGEN, Valencia,
CA).
RNA amplification and hybridization
Total RNA was subjected to two-cycle cDNA synthesis (Affymetrix,
Santa Clara, CA), with a slight modification described previously
(Mitsui et al., 2012). Human Genome U133 A2.0 arrays (Affymetrix)
were used. The data have been deposited to the Gene Expression
Omnibus repository (GSE42677).
Cell culture
A431 cells were purchased from ATCC (Manassas, VA). SCC13 cells
were kindly provided by Professor Rheinwald (Harvard Medical
Center, Boston, MA). Cells were grown in appropriate media. When
they reached 80% confluence, the cells were starved in empty media
for 24 hours, followed by stimulation with various cytokines at
indicated concentrations for 24 hours.
Scratch assay
A431 cells were grown in a 10% FBS-containing media. When the
cells reached 90% confluence, a wound was made by tip of a 200ml
pipet tip and the media were replaced with either 0.1% or 10% FBS-
containing media. The MMP7Ab was purchased from R&D Systems
(Minneapolis, MN) and added to the culture media at the indicated
concentrations. The wounds were photographed every 12 hours up to
36 hours. Measurement of wound area and calculation of percent
wound closure are described in the Supplementary Materials and
Methods online.
Quantitative RT–PCR
Preamplification quantitative RT–PCR technique was used for mea-
suring mRNA expression values in total RNA extracted from
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Figure 4. Blocking of matrix metallopeptidase 7 (MMP7) delayed the
migration of A431 cells. Scratch was made on a culture of A431 cells at
90% confluence and cells were cultured in 0.1% fetal bovine serum (FBS)–
containing media with or without indicated concentrations of anti-MMP7
antibody (MMP7Ab) for 36 hours. Cells were photographed every 12 hours.
(a–d) Representative images of area after a 36-hour cultivation with
(a) phosphate-buffered saline (PBS), (b) 20 ng ml1 of MMP7Ab,
(c) 200 ng ml1 of MMP7Ab, and (d) 2,000 ng ml1 of MMP7Ab. Two white
dotted lines depict the initial area. (e) The bar graph shows mean of percent
wound closure for each treatment after 36 hours. (f) The graph depicts the
chronological change of the percent wound closure for each condition. An
error bar shows SEM (n¼3). **Po0.01 between MMP7Ab2,000 and PBS and
MMP7Ab20 for a 24-hour treatment, and between MMP7Ab2,000 and PBS,
MMP7Ab20, and MMP7Ab200 for a 36-hour treatment (repeated measures
analysis of variance (ANOVA) with Tukey’s correction).
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microdissected samples according to the company’s instructions
(Applied Biosystems, Foster City, CA). Regular TaqMan RT–PCR
method was used to detect the signals in total RNA extracted from
cultured cells. All data were normalized to RPLP0/hARP. Primers
and probes used in this experiment are listed in Supplementary
Table S7 online.
Immunohistochemistry
Frozen skin sections were prepared and standard procedures were
used. Antibodies used in this experiment are listed in Supplementary
Table S8 online.
Statistical analysis
Microarray data were analyzed using R/Bioconductor packages
(www.r-project.org). The Harshlight package (Sua´rez-Farin˜as et al.,
2005) was used to scan Affymetrix chips for spatial artifacts.
Expression values were obtained using gcrma algorithm.
Expression values were linearly modeled in the limma package
framework. For the comparison of interest, the moderated t-test was
used to assess differential expression. P-values for each comparison
were adjusted for multiple hypotheses using the Benjamini–
Hochberg approach. Genes with false discovery rate of o0.05
and fold change of 43.0 were considered as differentially
expressed.
Statistical analyses of all RT–PCR data were performed using
Graphpad Prism ver.5 (GraphPad Software, La Jolla, CA). A
Po0.05 was considered as statistically significant.
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